Rilonacept | m-entrepreneurship.com

Product Name :
Rilonacept

Search keywords :
Rilonacept

drugId :
null

Target Vo:
Interleukin-1 alpha

Target Vo Short Name :
IL1A

Moa_Name:
Interleukin-1 alpha inhibitors

First Approval Country :
United States

First Approval Date Filter:
2008

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd

Active Indication_Name:
Pericarditis

In Active Indication_Name:
Deficiency of interleukin-1 receptor antagonist

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDX1 Antibody
HMGB1 Antibody
Ku80 Antibody: Ku80 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Ku80. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts